For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

These stories offer a glimpse into the lives of people touched by a new era of medicine.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Researchers focus on reversing the scarring that’s common to liver diseases.

A lung cancer researcher describes her journey toward a career in science at Novartis.